Journals
Publish with us
Publishing partnerships
About us
Blog
Case Reports in Hematology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Case Reports in Hematology
/
2020
/
Article
/
Tab 2
/
Case Report
Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review
Table 2
KRD-PACE dosing schedule for patient 1 and KRD-PACE dosing schedule for patient 2.
28d cycle
K
R
D
P
A
C
E
A: Patient 1, KRD-PACE schedule
Dose
20 mg/m
2
(day 1) then 56 mg/m
2
thereafter
25 mg
40 mg
10 mg/m
2
10 mg/m
2
400 mg/m
2
40 mg/m
2
Schedule
Days 1, 2, 8, 9, 15, 16
Days 1–21
Days 1–4
Days 1–4
Days 1–4
Days 1–4
Days 1–4
B: Patient 2, KRD-PACE schedule
Dose
20 mg/m
2
(day 1) then 27 mg/m
2
15 mg
40 mg
10 mg/m
2
10 mg/m
2
400 mg/m
2
40 mg/m
2
Schedule
Days 1,2
Days 1–21
Days 1–4
Days 1–4
Days 1–4
Days 1–4
Days 1–4